-
-
-
-
-
-
-
AnaptysBio (ANAB) PT Raised to $95 at Piper Sandler
-
-
-
-
-
-
-
AnaptysBio, Inc. (ANAB) Tops Q4 EPS by 71c
-
-
-
-
-
-
-
Vanda submits FDA application for rare skin disorder drug
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on AnaptysBio (ANAB)
-
-
-
-
-
-
-
AnaptysBio (ANAB) PT Raised to $59 at H.C. Wainwright
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on AnaptysBio (ANAB)
-
-
-
-
-
-
-
Anaptysbio (ANAB) Announces Stock Repurchase Plan
-
413,571 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

